Skip to content

The Effect of Buccal Acupuncture on Postoperative Nausea, Vomiting and Pain in Patients Undergoing Thyroid Surgery: A Randomized Controlled Trial

The Effect of Buccal Acupuncture on Postoperative Nausea, Vomiting and Pain in Patients Undergoing Thyroid Surgery: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000996
Enrollment
Unknown
Registered
2026-04-16
Start date
2026-05-02
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative nausea and vomiting,Postoperative pain

Interventions

Reserch Group:after induction of general anesthesia, the same physician performs cheek acupuncture intervention at bilateral neck points, upper neck points and back points, with needles retained until
Control group:Only general anesthesia was administered, and no cheek acupuncture intervention was performed.

Sponsors

Dalian Medical University Affiliated Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18 to 75 years (2) American Society of Anesthesiologists (ASA) physical status I-III (3) Body mass index (BMI) 18.5-28 kg/m² (4) Operation duration 1 to 3 hours (5) Patients undergoing elective radical thyroidectomy or partial thyroidectomy (6) Understand the purpose of the study, agree to the protocol, and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with pre-existing chronic pain in the observation area. (2) Regular use of drugs with known antiemetic properties. (3) Local infection or trauma at acupuncture points. (4) Trigeminal neuralgia and hemifacial spasm. (5) History of facial cosmetic surgery. (6) Coagulation disorders. (7) Long-term use of anticoagulants. (8) Severe diabetes mellitus, hypertension, coronary artery disease, severe hepatic or renal insufficiency. (9) Previous cerebrovascular events, mental disorders, or inability to communicate. (10) Postoperative admission to the intensive care unit (ICU). (11) Hypersensitivity to any drug used in the trial. (12) History of sedative, antidepressant, or anxiolytic use; history of drug or alcohol dependence.

Design outcomes

Primary

MeasureTime frame
The incidence of nausea and vomiting within 48 hours after the operation;VAS scores of pain at different time points after the operation;

Secondary

MeasureTime frame
Intraoperative dosage of propofol;Intraoperative dosage of remifentanil;Medication name, dosage and frequency of postoperative supplementary analgesics and antiemetics.;QoR-15 score at 48 h after surgery.; Postoperative sedation score.;PSQI on postoperative day 1 and 2;incidence of POSD at 48 h after surgery.;

Countries

The People's Republic of China

Contacts

Public ContactHou Dongnan

Dalian Medical University Affiliated Second Hospital

31922710@qq.com+86 177 0987 2323

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026